DSFH Acquires 50.01% Stake in Diagnostic Elite for SAR 70 Million

FAKEEH CARE -0.29%

FAKEEH CARE

4017.SA

34.90

-0.29%

Dr. Soliman Abdel Kader Fakeeh Hospital Company announced on January 1, 2026, an addendum regarding its previously disclosed acquisition of a 50.01% stake in Diagnostic Elite for SAR 70.0 million. The total investment consists of SAR 55.35 million payable in cash to Fakeeh Real Estate for 30,506 shares and SAR 14.65 million as direct capital contribution to fund Diagnostic Elite's planned expansion. According to an independent external valuation, the acquisition price represents a 38%-44% discount to the indicative fair value range of SAR 114-125 million for the stake.

Original announcement:

https://www.saudiexchange.sa/wps/portal/saudiexchange/newsandreports/issuer-news/issuer-announcements/issuer-announcements-details/?anId=92381&anCat=1&cs=4017&locale=ar

Important Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.